Literature DB >> 20486841

Protective effects of propofol against ischemia/reperfusion injury in rat kidneys.

Mehmet Fatih Yuzbasioglu1, Ahmet Aykas, Ergul Belge Kurutas, Tayfun Sahinkanat.   

Abstract

AIM: The purpose of this study was to investigate and compare the efficiency of propofol in the reduction of injury induced by free radicals in a rat model of renal ischemia/reperfusion (I/R).
METHOD: Twenty-four Wistar rats were divided into four groups in our study. Rats in the sham group underwent laparotomy and were made to wait for 120 min without ischemia. Rats in the control group were given nothing with ischemia-reperfusion. Rats in the I/R groups were given propofol (25 mg/kg) and 10% intralipid (250 mg/kg) ip, respectively, 15 min before the ischemia for 60 min followed by reperfusion for 60 min. The kidney tissues of the rats were taken under anesthesia at the end of the reperfusion period. Evaluation of biochemical malondialdehyde (MDA), superoxide dismutase, and catalase activities and histopathological analysis were performed with these samples.
RESULTS: I/R significantly increased MDA levels (p < 0.05). Histopathological findings of the control group confirmed that there was renal impairment by tubular cell swelling, interstitial edema, medullary congestion, and tubular dilatation. MDA levels were lower in the propofol group compared to control group (p < 0.05). In the propofol group, the level of histopathological scores is significantly decreased than control and intralipid groups in ischemia-reperfusion.
CONCLUSION: Our results demonstrate that I/R injury was significantly reduced in the presence of propofol. The protective effects of propofol may be due to their antioxidant properties. These results may indicate that propofol anesthesia protects against functional, biochemical, and morphological damage better than control in renal I/R injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486841     DOI: 10.3109/08860220903548940

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  8 in total

1.  Preparation and Monitoring of Small Animals in Renal MRI.

Authors:  Tamas Kaucsar; Adam Hosszu; Erdmann Seeliger; Henning M Reimann; Andrea Fekete
Journal:  Methods Mol Biol       Date:  2021

2.  Propofol Attenuates Airway Inflammation in a Mast Cell-Dependent Mouse Model of Allergic Asthma by Inhibiting the Toll-like Receptor 4/Reactive Oxygen Species/Nuclear Factor κB Signaling Pathway.

Authors:  Hong-Yi Li; Jing-Xia Meng; Zhen Liu; Xiao-Wen Liu; Yu-Guang Huang; Jing Zhao
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

Review 3.  Renal ischemia/reperfusion injury; from pathophysiology to treatment.

Authors:  Maryam Malek; Mehdi Nematbakhsh
Journal:  J Renal Inj Prev       Date:  2015-06-01

Review 4.  Opioids Preconditioning Upon Renal Function and Ischemia-Reperfusion Injury: A Narrative Review.

Authors:  Julio Palomino; Raquel Echavarria; Adriana Franco-Acevedo; Bibiana Moreno-Carranza; Zesergio Melo
Journal:  Medicina (Kaunas)       Date:  2019-08-23       Impact factor: 2.430

5.  Effects of Anesthetic Technique on the Occurrence of Acute Kidney Injury after Spine Surgery: A Retrospective Cohort Study.

Authors:  Jiwon Han; Ah-Young Oh; Chang-Hoon Koo; Yu Kyung Bae; Yong-Tae Jeon
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

6.  Propofol ameliorates renal ischemia/reperfusion injury by enhancing macrophage M2 polarization through PPARγ/STAT3 signaling.

Authors:  Zhaohui Liu; Yanli Meng; Yu Miao; Lili Yu; Qianjie Wei; Yuqing Li; Bing Zhang; Qiannan Yu
Journal:  Aging (Albany NY)       Date:  2021-06-10       Impact factor: 5.682

7.  Protective effects of propofol against hydrogen peroxide-induced oxidative stress in human kidney proximal tubular cells.

Authors:  Yu Mi Lee; Jin Woo Shin; Eun Ho Lee; Youngjin Moon; Young Joo Seo; Ji Yeon Kim; Joung Uk Kim
Journal:  Korean J Anesthesiol       Date:  2012-11-16

8.  Effects of propofol on renal ischemia/reperfusion injury in rats.

Authors:  Shun Yang; Wei-Ping Chou; Ling Pei
Journal:  Exp Ther Med       Date:  2013-09-18       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.